Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges

In children and adolescents with conduct disorder (CD), pharmacotherapy is considered when non-pharmacological interventions do not improve symptoms and functional impairment. Risperidone, a second-generation antipsychotic is increasingly prescribed off-label in this indication, but its efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Glennon, Jeffrey, Purper-Ouakil, Diane, Bakker, Mireille, Zuddas, Alessandro, Hoekstra, Pieter, Schulze, Ulrike, Castro-Fornieles, Josefina, Santosh, Paramala J., Arango, Celso, Kölch, Michael, Coghill, David, Flamarique, Itziar, Penzol, Maria J., Wan, Mandy, Murray, Macey, Wong, Ian C. K., Danckaerts, Marina, Bonnot, Olivier, Falissard, Bruno, Masi, Gabriele, Fegert, Jörg M., Vicari, Stefano, Carucci, Sara, Dittmann, Ralf W., Buitelaar, Jan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246122/
https://www.ncbi.nlm.nih.gov/pubmed/24337449
http://dx.doi.org/10.1007/s00787-013-0498-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246122/
https://www.ncbi.nlm.nih.gov/pubmed/24337449
http://dx.doi.org/10.1007/s00787-013-0498-3

Ejemplares similares